S. Clifford Schold - Concepedia

Author

S. Clifford Schold

Duke University

Also Known As

S. CLIFFORD SCHOLD, S. Clifford Schold

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Duke University Duke Medical Center University of Utah Duke University Hospital The University of Texas Southwestern Medical Center

About

S. Clifford Schold is an author at Duke University specializing in neuro-oncology, medicine, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	189
2	Neurology	2	2	29
3	Pathology	2	2	174
4	Cell Biology	1	1	160
5	Pharmacology	1	1	15

S. Clifford Schold

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas Henry Brem, M. Stephen Mahaley, Nicholas A. Vick, Journal of neurosurgery	1991	489
Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer Francisco A. Luque, Henry Furneaux, R Ferziger, Annals of Neurology	1991	399
Growth and Chemotherapeutic Response in Athymic Mice of Tumors Arising from Human Glioma-derived Cell Lines Dennis E. Bullard, S. Clifford Schold, Sandra H. Bigner, Journal of Neuropathology & Experimental Neurology Neuro-oncologyMedicineTumor WeightAthymic MiceBiological Microenvironments	1981	160
Enhancement of Nitrosourea Activity in Medulloblastoma and Glioblastoma Multiforme Henry S. Friedman, M. Eileen Dolan, Robert C. Moschel, JNCI Journal of the National Cancer Institute	1992	103
Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine Darryl C. Longee, Henry S. Friedman, Robert E. Albright, Journal of neurosurgery	1990	80
Distribution and Dosimetry of I-123-Labeled Monoclonal Antibody 81C6 in Patients with Anaplastic Glioma S. Clifford Schold, Michael R. Zalutsky, R. Edward Coleman, Investigative Radiology	1993	50
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plustemozolomide: A North American Brain Tumor Consortium study S. Clifford Schold, John G. Kuhn, Susan M. Chang, Neuro-Oncology	2000	35
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma Michael D. Prados, S. Clifford Schold, Howard A. Fine, Neuro-Oncology Neuro-oncologyRecurrent Malignant GliomaMedicinePharmacologyPharmacotherapy	2003	15
Phase II study of Didemnin B in central nervous system tumors: A Southwest Oncology Group study Sarah A. Taylor, Dorothy J. Giroux, Kurt A. Jaeckle, Investigational New Drugs Neuro-oncologyDidemnin BTumoral PathologyTumor InnervationMedicine	1998	14

Page 1